Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
NT-0796 by NodThera for Atherosclerosis: Likelihood of Approval
NT-0796 is under clinical development by NodThera and currently in Phase II for Atherosclerosis. According to GlobalData, Phase II drugs...
Data Insights
NT-0796 by NodThera for Inflammation: Likelihood of Approval
NT-0796 is under clinical development by NodThera and currently in Phase II for Inflammation. According to GlobalData, Phase II drugs...